1. Home
  2. FAMI vs ADVB Comparison

FAMI vs ADVB Comparison

Compare FAMI & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

BUY

Current Price

$1.44

Market Cap

7.8M

ML Signal

BUY

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$0.37

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
ADVB
Founded
2015
2014
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
8.4M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
FAMI
ADVB
Price
$1.44
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
600.1K
66.5K
Earning Date
08-04-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.28
52 Week High
$3.64
$4.10

Technical Indicators

Market Signals
Indicator
FAMI
ADVB
Relative Strength Index (RSI) 55.87 43.92
Support Level $1.11 $0.29
Resistance Level $1.43 $0.36
Average True Range (ATR) 0.14 0.03
MACD 0.02 0.00
Stochastic Oscillator 79.09 48.83

Price Performance

Historical Comparison
FAMI
ADVB

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: